US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
STORY CONTINUES BELOW THESE SALTWIRE VIDEOS (Reuters) - Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approveits Alzheimer's disease drug, donanemab, on June 10. A possible approval for …